Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Rituximab can cause skin issues, but baricitinib may help improve them.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

Denosumab may cause alopecia areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Deuruxolitinib is approved to treat severe alopecia areata in adults.